NEW YORK, March 14 (GenomeWeb News) - Oxford Biomedical Research and Qualyst have inked a deal to create a product line of cytochrome P450-inhibition assays to be sold as Accuratet, the companies said today.
Already have a GenomeWeb or 360Dx account?Login Now.
Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.
A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.
In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.
A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.